Table 3. Demographic and clinical characteristics of study participants according to the need of h-CPAP.
Variables | Room air or oxygen only | h-CPAP application | p-value |
---|---|---|---|
N = 31 | N = 10 | ||
Timing of infection | |||
1st wave (Mar-Aug 2020) | 10 (32.2) | 0 | 0.040 |
2nd wave (Sept-Dec 2020) | 16 (51.6) | 3 (30.0) | 0.205 |
3rd wave (Jan-Mar 2021) | 5 (16.1) | 7 (70.0) | 0.003 |
Demographic and obstetric variables | |||
Maternal age (years) | 31.6 ±4.9 | 33.3 ± 6.4 | 0.397 |
BAME | 7 (22.6) | 3 (30.0) | 0.683 |
Pregestational BMI ≥30 Kg/m2 | 4 (12.9) | 4 (40.0) | 0.082 |
Comorbidities | 6 (19.4) | 1 (10.0) | 0.660 |
Nulliparity | 10 (32.3) | 4 (40.0) | 0.712 |
Pregnancy complications | 15 (48.4) | 6 (60.0) | 0.719 |
GA at hospital admission (weeks) | 31.4 ± 5.6 | 29.4 ± 5.0 | 0.318 |
Laboratory data at hospital admission | |||
White blood cells (10^3/uL) | 7.93 ± 3.3 | 9.49 ± 4.3 | 0.260 |
Lymphocytes (10^3/uL) | 1.2 ± 0.6 | 1.1 ± 0.7 | 0.560 |
Platelets (10^3/uL) | 202.1 ± 68.5 | 253.8 ± 125.3 | 0.125 |
D-dimer (ng/mL) | 713.4 ± 801.5 | 651.0 ± 539.5 | 0.858 |
(n = 28) | (n = 8) | ||
Fibrinogen (mg/dL) | 512.6 ±144.2 | 524.8 ± 157.4 | 0.839 |
ALT (U/L) | 29.7 ± 34.8 | 38.9 ± 28.1 | 0.478 |
LDH (U/L) | 185.3 ±39.3 | 213.0 ± 55.3 | 0.111 |
CRP (mg/dL) | 3.0 ± 2.9 | 6.1 ± 4.4 | 0.021 |
Chest X-ray findings upon hospital admission | |||
Involvement of ≥3 lobes | 3 (9.7) | 8 (80.0) | <0.001 |
Bilateral involvement | 14 (45.2) | 10 (100.0) | 0.002 |
Lobe involvement | |||
• Right Lower | 19 (61.3) | 10 (100.0) | 0.021 |
• Left Lower | 13 (41.9) | 10 (100.0) | 0.002 |
• Right middle | 7 (22.6) | 9 (90.0) | <0.001 |
• Lingula | 8 (25.8) | 9 (90.0) | <0.001 |
• Right Upper | 1 (3.2) | 3 (30.0) | 0.039 |
• Left Upper | 5 (16.1) | 2 (20.0) | 1.000 |
Footnotes: Data shown as mean ± standard deviation or number (percentage).
BAME, Black, Asian, and minor ethnicity; BMI, Body Mass Index; h-CPAP, helmet continuous positive airway pressure; GA, gestational age.